首席执行官致辞

GEXVal Inc. started its journey in 2018 at Shonan iPark (Kanagawa, Japan), focusing on research and development of drugs for rare and untreatable diseases.

I have been engaged in drug discovery for over decades, but it was only recently when I attended an international conference for a rare disease sponsored by a patient advocacy group, that I realized the true seriousness of “access to medicine” issues that patients and families of rare disease1) are facing with.  Together with colleagues who share the same thoughts, we spun-off from a pharmaceutical company.

From day one, we have been getting enormous support from various patient advocacy groups, medical professionals, and investors across the globe.  As one united team who share the same goal, we always consider patients and families “first” and committed to address unmet medical needs. In 2021, we established a wholly owned subsidiary in Australia dedicated to clinical development.  We are currently preparing for Ph2 studies.

To date, drug discovery for rare diseases is becoming the mainstream in the pharma industry - more than half of recently approved drugs are for rare diseases.  Yet there is no approved drug for over 90% of rare diseases, meaning that patients and families are still facing serious “access to medicine” issues.

In the bitter reality that there is not enough medicine, we envision the society where people with rare diseases have stress-free access to medicine just like others.  We strive to deliver innovative and life-changing medicines to patients and families who live with rare and untreatable diseases, leaving no one behind.

2024年5月 

嘉惟思远制药有限公司　董事长 

加藤珠兰

1) Rare disease: Definition varies between countries. Japan (<50,000; <4 in 10,000, with population of 128 Million), US (<200,000;  <6.37 in 10,000 with population of 1400 Million), EU (<250,000; <5 in 10,000 with population of 514 Million).

 

企业理念

VISION & MISSION

Leaving no one behind
GEXVal tackles Access to Medicine

GEXVal is fully committed

to bringing hope and smile to those

who are waiting for better treatment options

Our VISION

For patients and families who live with
Rare and Intractable Diseases

GEXVal always considers patients-first

and strives to deliver innovative and affordable medicines to those who are waiting for
better treatment options

Our MISSION

GEXVal is
Purposed to RepurposeⓇ

shelved drugs for patients and families who live
with
rare and intractable diseases

 

Our STRATEGY

Drugs for Rare Diseases- Still More To Do

 

Definition of “rare disease” varies between countries

    • Japan (<50,000、<4 in 10,000, with population of 128 Million)

    • US (<200,000、<6.37 in 10,000 with population of 1400 Million)

    • EU (<250,000、<5 in 10,000 with population of 514 Million)

 

 

 

> 7000 rare diseases Only 5% have
approved treatments
1/10 affected
by rare diseases		 80% are
genetic disorders
Orphan Drugs
Over 500 in development
> 50% of recent FDA approvals		 Incentives have created
framework and opportunity
for alternative approaches

 

 

公司名称的由来

在药物研发过程中会衍生出许多的化合物，其中只有少数会最终成为药物。大多数的化合物在问世之前便遭埋没，其中不乏仍具有很高的研发潜力的化合物。我们通过重新定位研究，找出这些具有再研发潜力的化合物，塑造并赋予其新的价值，即Generate Extra Value，本公司名称GEXVal也由此而来。

嘉惟思远
公司名出自古诗词”任大者思远，思远者忘近”，同时取英文名的谐音。寓意我们祈求美好事物，统筹规划，致力于把创新药带给患者的理念。

 

Generate Extra Value

to deliver cost-effective, innovative treatment options to improve health and QoL of patients and families affected by rare and intractable diseases

 

商标的含义

企业的象征

我们公司以日本传统的装饰带“花纸绳”编织的蝴蝶作为商标图案。花纸绳是7世纪左右从隋朝传入日本的，后来在日本独自发展成了装饰赠品的饰件。花纸绳的编织法中有一种是用于护身符袋的十字结。结的正面为“口”字，反面为“十”字的形状，两者合二为一时，就变成了“叶”字（日文称为叶结，有如愿以偿的绳结之意）。

本公司的愿望是早日将药物交给患者使用。我们的企业象征中就蕴含着希望如愿以偿的期许。

企业的颜色

GEXVal的企业颜色是小紫色。由于我们的重点罕见病项目的患者群体采用紫色作为象征颜色，而且有鉴于本公司商标上的图案为“细带闪蛱蝶”（日文发音也是小紫色），因此我们选用小紫色作为企业颜色。

小紫色类似于白棠子树的果实的颜色，为典雅的深紫色。它是日本古典的颜色，七世纪中叶的日本书纪中也有相关记载，属于日本的冠位“七色十三阶冠”中的高贵色彩。

 

'Komurasak' Butterfly
Scientific name: Apatura metis substituta

蛱蝶平常翅膀多半是闭合着的，乍看之下是普通棕色的蝴蝶，但是当蛱蝶在下午到晚上期间四处活跃飞舞时，雄蛱蝶翅膀内侧的鳞片会随着光线的变化发出鲜艳的紫色光芒，因此被称为紫蛱蝶。紫蛱蝶几乎遍布日本全国各地，上至北海道下至九州。

在本公司办公室的所在地-神奈川县，紫蛱蝶也有分布并且被列入濒危物种红色名录中。紫蛱蝶的主要栖息地是柳树自然生长的河川区域，但令人遗憾的是由于城市开发和河川泛滥的关系，紫蛱蝶的个体数量似乎已显著减少。

'Komurasaki' Plant
Scientific name: Callicarpa dichotoma

分布在台湾、中国的温带至亚热带地区，可见于日本本州以南至琉球群岛一带。由于其体积比同属的紫珠略小，因此被命名为“小紫珠”，实际上，小紫珠的紫色果实缀满枝头，晶晶泛彩的模样更加优美奢华。

众所周知10月至11月是小紫珠结果的时期，但似乎很少有人注意到6月至8月娇然绽放的淡紫色花朵。

Show more information about GEXVal

公司概要

详细

团队

详细